Results 1 to 10 of about 2,159,024 (242)

Anticardiolipin antibodies in patients with Behcet's disease

Biomolecules & Biomedicine, 2011
The aims of this study are to determine anticardiolipin antibodies in patients with Sy Behcet and to determine correlation between the levels of anticardiolipin antibodies in serum in patients with clinic systemic and ocular manifestations.
Maja Zivkovic, Marko Zlatanovic, Gordana Zlatanovic, Jasmina Djordjevic-Jocic, Sonja Cekic   +4 more
doaj   +3 more sources

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks [PDF]

International Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour, Mansour Salesi, Fereshteh Keikhaei, Mohammad J. Tarrahi, Zahra Khani, Hassan Salehi   +5 more
doaj   +2 more sources

From Undifferentiated Connective Tissue Disease to Common Variable Immunodeficiency: A Novel NFKB1 Mutation in a Pediatric Case. [PDF]

Clin Case Rep
ABSTRACT Common variable immunodeficiency (CVID) may initially manifest as undifferentiated connective tissue disease (UCTD) in the absence of recurrent infections or hypogammaglobulinemia. In patients presenting with warning signs, neither older age nor normal immunoglobulin levels should preclude consideration of CVID; early genetic testing is ...
Hu YJ, Hao S, Feng D, Huang BX, Huang WY.   +4 more
europepmc   +2 more sources

Cytotoxic T-cell deficiency and sustained B-cell activation in serofast syphilis: a prospective observational study [PDF]

Frontiers in Immunology
IntroductionThe serofast state, defined by persistent non-treponemal reactivity after adequate therapy for syphilis, remains a clinically relevant yet poorly understood condition.
Konrad Kaminiów, Martyna Kiołbasa, Katarzyna Napiórkowska-Baran, Katarzyna Napiórkowska-Baran, Maciej Pastuszczak   +4 more
doaj   +2 more sources

Thrombotic Antiphospholipid Syndrome: A Long Term Follow-up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study. [PDF]

Am J Reprod Immunol
ABSTRACT Problem There is a paucity of studies on the incidence and predictors of thrombotic antiphospholipid syndrome (APS) after pregnancy in patients with recurrent pregnancy loss (RPL) and antiphospholipid antibodies (aPL). This prospective study aimed to assess the long‐term prognosis, including the occurrence of thrombosis and associated risk ...
Ashio M, Kitaori T, Yano Y, Banno C, Ide S, Yoshihara H, Goto S, Otani T, Sugiura-Ogasawara M.   +8 more
europepmc   +2 more sources

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Journal of Experimental Medicine, 1994
Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipid syndrome (APS) directly bind to beta 2- glycoprotein I (beta 2-GPI), which is adsorbed to an oxidized polystyrene surface.
E. Matsuura, Y. Igarashi, T. Yasuda, D. Triplett, T. Koike   +4 more
exaly   +2 more sources

A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)

Journal of Thrombosis and Haemostasis, 2006
Summary.  We prospectively examined whether there is an association between elevated anticardiolipin antibody levels and the risk for a future first venous thrombosis (VT) in a general population.
Suzanne Cannegieter
exaly   +2 more sources

Evaluation of Serum Anticardiolipin Antibodies and D-dimer in Recipients of COVID-19 Vaccines in Ado-Ekiti, Ekiti State, Nigeria

Journal of Applied Sciences and Environmental Management, 2023
Coronavirus disease 2019 (COVID-19) manifests itself in a variety of ways, implying a wide range of host autoimmune responses which could lead to disseminated intravascular coagulation.
O. O. Odewusi, J. J. Dodo, F. E. Omotayo, S. O. Obadire, E. A. Omon, M. O. Oguntuase, O. A. Alake   +6 more
doaj   +1 more source

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

Annals of the Rheumatic Diseases, 2021
Background Reports of severe COVID-19 being associated with thrombosis, antiphospholipid antibodies (APLA), and antiphospholipid syndrome have yielded disparate conclusions.
Uriel Trahtemberg, Robert Rottapel, C. D. dos Santos, Arthur S. Slutsky, A. Baker, Marvin J. Fritzler   +5 more
semanticscholar   +1 more source

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Journal of Thrombosis and Haemostasis, 2021
Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show differences in positive/negative agreement and titers between solid phase platforms.
A. Vandevelde, W. Chayoua, B. de Laat, J. Gris, G. Moore, J. Musial, S. Zuily, D. Wahl, K. Devreese   +8 more
semanticscholar   +1 more source